nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.0045	0.0045	CcSEcCtD
Zanamivir—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00441	0.00441	CcSEcCtD
Zanamivir—Delusion—Prednisone—chronic obstructive pulmonary disease	0.00439	0.00439	CcSEcCtD
Zanamivir—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00439	0.00439	CcSEcCtD
Zanamivir—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00438	0.00438	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00429	0.00429	CcSEcCtD
Zanamivir—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00416	0.00416	CcSEcCtD
Zanamivir—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00414	0.00414	CcSEcCtD
Zanamivir—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00414	0.00414	CcSEcCtD
Zanamivir—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00409	0.00409	CcSEcCtD
Zanamivir—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00406	0.00406	CcSEcCtD
Zanamivir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00398	0.00398	CcSEcCtD
Zanamivir—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00393	0.00393	CcSEcCtD
Zanamivir—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00391	CcSEcCtD
Zanamivir—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Zanamivir—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00385	0.00385	CcSEcCtD
Zanamivir—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00383	0.00383	CcSEcCtD
Zanamivir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Zanamivir—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00376	0.00376	CcSEcCtD
Zanamivir—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00376	0.00376	CcSEcCtD
Zanamivir—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Zanamivir—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00373	0.00373	CcSEcCtD
Zanamivir—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Zanamivir—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Zanamivir—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Zanamivir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Zanamivir—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Zanamivir—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Zanamivir—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Zanamivir—Delirium—Prednisone—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Zanamivir—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00354	0.00354	CcSEcCtD
Zanamivir—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00354	0.00354	CcSEcCtD
Zanamivir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Zanamivir—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Zanamivir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0035	0.0035	CcSEcCtD
Zanamivir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00349	0.00349	CcSEcCtD
Zanamivir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00347	0.00347	CcSEcCtD
Zanamivir—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00347	0.00347	CcSEcCtD
Zanamivir—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Zanamivir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Zanamivir—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Zanamivir—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00334	0.00334	CcSEcCtD
Zanamivir—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.0033	0.0033	CcSEcCtD
Zanamivir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Zanamivir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Zanamivir—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Zanamivir—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Zanamivir—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Zanamivir—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Zanamivir—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00311	0.00311	CcSEcCtD
Zanamivir—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00311	0.00311	CcSEcCtD
Zanamivir—Agitation—Montelukast—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Zanamivir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00302	0.00302	CcSEcCtD
Zanamivir—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00302	CcSEcCtD
Zanamivir—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Zanamivir—Cough—Formoterol—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Zanamivir—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Zanamivir—Cough—Montelukast—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Zanamivir—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Zanamivir—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Zanamivir—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Zanamivir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Zanamivir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Zanamivir—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Zanamivir—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Zanamivir—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Zanamivir—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Zanamivir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Zanamivir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Zanamivir—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Zanamivir—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.0029	CcSEcCtD
Zanamivir—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0029	0.0029	CcSEcCtD
Zanamivir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Zanamivir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Zanamivir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00287	0.00287	CcSEcCtD
Zanamivir—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Zanamivir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.00285	CcSEcCtD
Zanamivir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00284	CcSEcCtD
Zanamivir—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Zanamivir—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Zanamivir—Infection—Formoterol—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Zanamivir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Zanamivir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Zanamivir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Zanamivir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Zanamivir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Zanamivir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Zanamivir—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Zanamivir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00274	CcSEcCtD
Zanamivir—Infection—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00274	CcSEcCtD
Zanamivir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Zanamivir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Zanamivir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Zanamivir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00268	0.00268	CcSEcCtD
Zanamivir—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00266	CcSEcCtD
Zanamivir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00264	CcSEcCtD
Zanamivir—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00262	CcSEcCtD
Zanamivir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Zanamivir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Zanamivir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Zanamivir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Zanamivir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Zanamivir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Zanamivir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00245	0.00245	CcSEcCtD
Zanamivir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Zanamivir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Zanamivir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Zanamivir—Pain—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Zanamivir—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Zanamivir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00238	0.00238	CcSEcCtD
Zanamivir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Zanamivir—Pain—Montelukast—chronic obstructive pulmonary disease	0.00236	0.00236	CcSEcCtD
Zanamivir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Zanamivir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.00233	CcSEcCtD
Zanamivir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.00233	CcSEcCtD
Zanamivir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Zanamivir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Zanamivir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Zanamivir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Zanamivir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Zanamivir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Zanamivir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Zanamivir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Zanamivir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Zanamivir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00225	0.00225	CcSEcCtD
Zanamivir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Zanamivir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Zanamivir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Zanamivir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Zanamivir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Zanamivir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Zanamivir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Zanamivir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Zanamivir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Zanamivir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Zanamivir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Zanamivir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Zanamivir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Zanamivir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Zanamivir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Zanamivir—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Zanamivir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Zanamivir—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Zanamivir—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Zanamivir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00211	CcSEcCtD
Zanamivir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Zanamivir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Zanamivir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Zanamivir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Zanamivir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Zanamivir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Zanamivir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Zanamivir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Zanamivir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00198	CcSEcCtD
Zanamivir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00196	CcSEcCtD
Zanamivir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00193	CcSEcCtD
Zanamivir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00193	CcSEcCtD
Zanamivir—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00192	0.00192	CcSEcCtD
Zanamivir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00191	CcSEcCtD
Zanamivir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00189	CcSEcCtD
Zanamivir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Zanamivir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Zanamivir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00182	CcSEcCtD
Zanamivir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00182	0.00182	CcSEcCtD
Zanamivir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00182	CcSEcCtD
Zanamivir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Zanamivir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Zanamivir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Zanamivir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Zanamivir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Zanamivir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Zanamivir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Zanamivir—Headache—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Zanamivir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Zanamivir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00175	0.00175	CcSEcCtD
Zanamivir—Rash—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00174	CcSEcCtD
Zanamivir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00174	CcSEcCtD
Zanamivir—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Zanamivir—Headache—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Zanamivir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00169	CcSEcCtD
Zanamivir—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Zanamivir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Zanamivir—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Zanamivir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Zanamivir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Zanamivir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Zanamivir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Zanamivir—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Zanamivir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Zanamivir—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00162	0.00162	CcSEcCtD
Zanamivir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Zanamivir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00157	CcSEcCtD
Zanamivir—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00157	CcSEcCtD
Zanamivir—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Zanamivir—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Zanamivir—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00152	CcSEcCtD
Zanamivir—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Zanamivir—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Zanamivir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Zanamivir—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Zanamivir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Zanamivir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Zanamivir—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Zanamivir—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Zanamivir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Zanamivir—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Zanamivir—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Zanamivir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Zanamivir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Zanamivir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Zanamivir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Zanamivir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Zanamivir—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Zanamivir—Infection—Prednisone—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Zanamivir—Shock—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Zanamivir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Zanamivir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Zanamivir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Zanamivir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000963	0.000963	CcSEcCtD
Zanamivir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000961	0.000961	CcSEcCtD
Zanamivir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00096	0.00096	CcSEcCtD
Zanamivir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000955	0.000955	CcSEcCtD
Zanamivir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000955	0.000955	CcSEcCtD
Zanamivir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000913	0.000913	CcSEcCtD
Zanamivir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000906	0.000906	CcSEcCtD
Zanamivir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000906	0.000906	CcSEcCtD
Zanamivir—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00088	0.00088	CcSEcCtD
Zanamivir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000876	0.000876	CcSEcCtD
Zanamivir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000876	0.000876	CcSEcCtD
Zanamivir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000816	0.000816	CcSEcCtD
Zanamivir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000795	0.000795	CcSEcCtD
Zanamivir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000758	0.000758	CcSEcCtD
Zanamivir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000733	0.000733	CcSEcCtD
Zanamivir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000704	0.000704	CcSEcCtD
Zanamivir—Rash—Prednisone—chronic obstructive pulmonary disease	0.000699	0.000699	CcSEcCtD
Zanamivir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000698	0.000698	CcSEcCtD
Zanamivir—Headache—Prednisone—chronic obstructive pulmonary disease	0.000694	0.000694	CcSEcCtD
Zanamivir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000658	0.000658	CcSEcCtD
